Background. Few studies have specifically observed the relationship of sarcopenia, visceral
obesity, or their joint effects with lean NAFLD in patients with diabetes. We aimed to …

Aims Recent epidemiological studies have suggested an association between sarcopenia
and non-alcoholic fatty liver disease (NAFLD) in the general population, prompting our …

Background & aims Non-alcoholic fatty liver disease (NAFLD) is significantly related to
sarcopenia as well as obesity and its associated comorbidities. This cross-sectional study …

Background The association between nonalcoholic fatty liver disease (NAFLD) and
sarcopenia has been suggested. We investigated the association between sarcopenia and …

Methods In total, 2,191 subjects completed a health checkup program, including abdominal
ultrasonography and FibroScan. Subjects were classified into the following four categories …

Background Sarcopenic obesity, central obesity combined with decreased skeletal muscle
mass, is identified to be associated with metabolic syndrome and cardiovascular diseases; …

Background Currently, both non-alcoholic fatty liver disease (NAFLD) and sarcopenia have
attracted extensive attention in public health. However, the relationship between NAFLD and …

There is exponential interest in non-alcoholic fatty liver disease (NAFLD) as a cause of
chronic liver disease in the last decade [1]. The epidemic of obesity due to changes in life …

Although the association of nonalcoholic fatty liver disease (NAFLD) with obesity or
sarcopenia is known, few studies have investigated the combined effect of various body …

BACKGROUND Skeletal muscle, a key insulin target organ, has been reported to be
associated with diabetes mellitus (DM). Compared to non-diabetic patients, diabetic patients …